In addition to AAALAC accreditation the facility also completes the renovation of its two main barriers.
At Envigo we have extensive experience in conducting radiolabelled studies in a wide range of plants and crops and can provide expert advice on study design and regulatory requirements.
Scientific findings establish the effectiveness of Envigo's new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection
SHrN is triple-immunodeficient and is ideally suited for tumor xenografts in oncology and immunology-related research applications.
In order to provide you with a more customized experiencewhen viewing our models please select your location:
Copyright © 2017 Envigo